Opko Health Inc. (NASDAQ:OPK) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. In a report released ...

OPKO Health, Inc. Conference call begins at 4:30 p.m. Eastern time today. MIAMI, Nov. 07, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial ...

OPKO Health, Inc. (NASDAQ: OPK) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 25, the ...

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company. The company is engaged in discovering, developing, commercializing and expertise ...

Shares of Opko Health have decreased by 27.39% in the past year. An investor who bought shares of Opko Health at the beginning of the year would take a loss of $0.03 per share if they sold it today.

WESTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced the creation of a Scientific Advisory Board to provide counsel and ...

What: Shares of Opko Health , a biopharmaceutical and diagnostics company aiming to treat a variety of diseases and disorders, were slammed and sank as much as 15% on Thursday after the company ...

OPKO received last December a $295 million upfront payment from Pfizer as part of a long-term agreement for the commercialization of Lagova hGH-CTP, ...

OPKO has $265.6M in receivables and $97M in inventory. Its $283M short-term and $370M in long-term liabilities are covered. Free cash flow leaves OPKO with a cash runway for the next three years.